Study finds conflicting guidelines for statin use for black patients | PCSK9 inhibitor may cut heart, stroke risks in patients with CVD | Risk score predicts mortality for patients on heart transplant list
March 22, 2017
ASNC SmartBrief
News for nuclear cardiology and cardiovascular imaging professionals
Top Stories
Study finds conflicting guidelines for statin use for black patients
A study in JAMA Cardiology found conflicting medical guidelines on prescribing statin drugs to black patients. Data showed about 25% of blacks who would be eligible for a cholesterol-lowering statin medication under American College of Cardiology/American Heart Association guidelines would not be under new recommendations from the US Preventive Services Task Force.
HealthDay News (3/18) 
LinkedIn Twitter Facebook Google+ Email
PCSK9 inhibitor may cut heart, stroke risks in patients with CVD
PCSK9 inhibitor may cut heart, stroke risks in patients with CVD.
(Jean-Sebastien Evrard/AFP/Getty Images)
A study in The New England Journal of Medicine showed use of the cholesterol-lowering drug Repatha, a PCSK9 inhibitor, along with statins, was associated with lower risks of heart attack, stroke, cardiovascular revascularization and extended major adverse cardiovascular events, but the drug's annual $14,523 price tag could put it out of reach for some. The study involved 27,564 adults who had experienced a heart attack or pain associated with narrowed arteries in the lower extremities.
United Press International (3/17) 
LinkedIn Twitter Facebook Google+ Email
Other News
Medical Focus
Improved glycemic control in diabetes seen with sacubitril/valsartan
A study presented at the American College of Cardiology's Scientific Sessions showed that type 2 diabetes patients who received sacubitril/valsartan, a combination of neprilysin inhibitor and angiotensin II receptor blocker, had a greater reduction in A1C and a nonsignificant reduction in plasma glucose, compared with those on enalapril. Researchers based their findings on a cohort of 3,778 patients with diabetes and heart failure with reduced ejection fraction. (3/18) 
LinkedIn Twitter Facebook Google+ Email
Breast cancer patients who exercise may reduce their CV risks
Survey data from 4,015 patients with non-metastatic breast cancer showed a lower risk of cardiovascular events and death from coronary heart disease among those who had a high level of physical activity, compared with those who had low activity levels. The study, presented at the American College of Cardiology's annual meeting, found patients who had moderate and intermediate activity levels also saw reduced CV risks.
Healio (free registration)/Cardiology Today (3/20) 
LinkedIn Twitter Facebook Google+ Email
Other News
Regulatory & Policy
Alert on adverse events risk in Abbott's Absorb BVS released by FDA
The FDA has issued a letter alerting health care providers about the increased rates of major adverse cardiac events and stent thrombosis associated with use of Abbott Vascular's Absorb bioresorbable vascular scaffold, compared with the company's Xience metal stent. The agency advises clinicians to follow the instructions in the device's labeling for optimal device implantation and target heart vessel selection while it collaborates with Abbott to further analyze the causes of these high rates.
Medscape (free registration) (3/18),  MedPage Today (free registration) (3/18) 
LinkedIn Twitter Facebook Google+ Email
GOP lawmakers debate AHCA revisions ahead of planned House vote
GOP lawmakers debate AHCA revisions ahead of planned House vote
(Brendan Hoffman/Getty Images)
The American Health Care Act will undergo some changes before a House floor vote on Thursday, said Speaker Paul Ryan, R-Wis., who said he remains confident it will ultimately pass. Republican Study Committee leaders gave their support Friday after the White House agreed to include an option for states to integrate a work requirement into Medicaid programs, add a Medicaid block grant option and offer larger tax credits for lower-income, older Americans.
Reuters (3/20),  Morning Consult (3/17),  The Hill (3/17) 
LinkedIn Twitter Facebook Google+ Email
One week left to save with NC Today early bird
Save $100 with Early Bird Registration! Register by March 30 and save $100 off your registration fee. Not an ASNC member? Join now and save even more!
LinkedIn Twitter Facebook Google+ Email
Learn more about ASNC:
ASNC Home | Join ASNC | Online Education
Live Meetings | Journal of Nuclear Cardiology
Holding on to anger is like grasping a hot coal with the intent of throwing it at someone else; you are the one who gets burned.
religious scholar
LinkedIn Twitter Facebook Google+ Email
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Christopher Black
Editor  -  Tara Rosenzweig
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information